Tohoku J. exp. Med., 1979, 129 (1), 101-102-Rats with hypercalcemia induced by injection of vitamin D2 had a decreased thyroid somatostatin content, whereas the somatostatin content in their pancreas was almost within the normal range.
This suggests that somatostatin in different organs acts specifically on each particular organ as a local hormone or hormonelike substance.
somatostatin; thyroid; pancreas; local hormone; vitamin D2 Somatostatin (growth hormone release-inhibiting factor) exists in various organs such as the hypothalamus, central nervous system, thyroid, gastro-intestinal tract and pancreas Hokfelt et al. 1975 ). This study was performed in order to investigate if somatostatin in different organs responds concurrently and uniformly to a given stimulus.
MATERIALS AND METHODS
Eight male Wistar strain rats weighing 200 to 250 g were given vitamin D2 (200,000 units/day, Ergocalciferol, Eisai, Japan) by daily subcutaneous injections for 17 days. They were decapitated, together with eight control rats which had had no injection, and their thyroid and pancreas were removed.
The thyroid and pancreas were extracted by use of 1 N acetic acid and the extracts were boiled, rapidly chilled and centrifuged and the supernatants were lyophilized. The residues were dissolved in 0.05M veronal buffer (pH 7.5) and measured for somatostatin and calcitonin (CT) contents by radioimmunoassay. Antisera against somatostatin and CT were prepared by injections of synthetic somato statin or human CT (Peptide Institute, Osaka, Japan) conjugated to bovine serum albumin using glutaraldehyde. 
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